Background: Anemia is extremely common among patients admitted to pediatric intensive care. Alternative treatments to transfusions such as intravenous iron must be considered. There are no published data for a prospective intravenous (IV) iron study focused in the critically ill children. The objective is to examine the safety and efficacy of intravenous iron sucrose infusion to manage anemia in pediatric critical care. A secondary objective is to examine the effect of different dose regimens of iron sucrose (3, 5, and 7 mg/kg dose). Procedure: Prospective investigation of intravenous iron sucrose utilization at a tertiary pediatric intensive care unit between October 2017 and November 2022. Results: In all 115 patients received a total of 616 infusions of IV iron. Transferrin saturation index (TSI) was the most common altered iron deficiency biomarker (91.8%). After IV iron treatment, hemoglobin showed a significant increase within a 30-day follow-up (9.2 vs. 11.6 g/dL, p
CITATION STYLE
Butragueño-Laiseca, L., de la Mata Navazo, S., Sánchez Galindo, A. C., & Santiago Lozano, M. J. (2024). Intravenous iron for critically ill children. Comparison of three dose regimens. Pediatric Blood and Cancer, 71(1). https://doi.org/10.1002/pbc.30734
Mendeley helps you to discover research relevant for your work.